Explore the public record ↗
ROIV · Roivant Sciences Ltd.
Compare company and executive activity with congressional disclosures. Coinciding events do not establish coordination or wrongdoing.
Loading SEC filings and reported buybacks…
Compare company and executive activity with congressional disclosures. Coinciding events do not establish coordination or wrongdoing.
Loading SEC filings and reported buybacks…
Open-market or private purchases of non-derivative securities reported by officers and directors (code P). Grants, option exercises, and sales are excluded. These are personal transactions, not company buybacks.
Some ownership filings could not be loaded. Results are incomplete; this does not mean no purchases occurred.
Free includes up to 3 qualifying purchases from the latest 20 ownership filings and the latest reported buyback period. Plus unlocks older available filing pages and reported buyback history.
Compare plansReported cash payments to repurchase common stock, in US dollars. Periods can overlap and include year-to-date totals; do not add these rows together. These are reported payments, not announcement amounts or daily trades.
| Reporting period | Cash paid (USD) | Filed | Source |
|---|---|---|---|
| 2026-04-01 – 2026-06-30 | $206,729,000.00 | 2026-08-06 | 10-Q ↗ |